Ferritin plays a key role in determining the intracellular fate of iron and is highly regulated by the iron status of the cell. We have identified a cis-acting element in the transcribed but nontranslated 5' leader sequence of human ferritin heavy-chain mRNA. In transiently transfected murine fibroblasts, the presence of a 157-nucleotide region of the 5' leader sequence was found to be necessary for iron-dependent regulation of ferritin biosynthesis. Further, this 5' leader region is sufficient to transfer iron-mediated translational control to the expression of a heterologous gene product, chloramphenicol acetyltransferase.
Ferritin is the major intracellular repository of iron and exists as a heteropolymer of 24 subunits containing both heavy and light chains (1) . It serves to sequester and thereby detoxify iron not otherwise utilized for cellular metabolism (2) . A more active role of ferritin has been suggested (3) , in which iron sequestration may limit and regulate iron availability for cellular metabolism. Ferritin's key role is highlighted by the following observations. (i) All eukaryotic cells investigated thus far have been shown to express ferritin (4) . (ii) Cellular proliferation is dependent on the availability of iron, and ferritin levels are closely regulated during normal proliferation and have been found to be abnormal in various malignancies (5, 6) . (iii) Ferritin in the cells lining the duodenal mucosa is likely to regulate intestinal iron absorption. Furthermore, since one ofthe most common autosomal recessive disorders, hereditary hemochromatosis, is characterized by pathologically increased absorption of dietary iron, abnormal regulation of ferritin expression or abnormal ferritin function could play a major role in this disorder (7) . Thus, the regulation of ferritin levels by iron is the means by which ferritin can both influence and respond to iron homeostasis.
It is therefore important to elucidate the mechanisms by which ferritin gene expression is regulated. Munro and his colleagues (8, 9) suggested a translational regulation of ferritin expression in rat liver, based on two observations: (i) actinomycin D does not inhibit the stimulatory effect of iron on ferritin expression and (ii) cytoplasmic ferritin mRNA shifts from an inactive messenger-ribonucleoprotein pool to translationally active polysomes upon iron induction. Similar results were obtained for reticulocytes and liver of bullfrog tadpoles (10, 11) . In further support of translational control of ferritin expression, cytoplasmic mRNA levels were shown to remain constant over a wide range of biosynthetic rates induced by iron (9) . The recent cloning of the human ferritin heavy-chain cDNA and gene (12) (13) (14) (15) has allowed us to directly address this question of the mechanism of biosynthetic regulation at a molecular level.
Previous work showed that a 7.2-kilobase (kb) HindIII genomic DNA fragment (pUCM11) is actively transcribed in stably transformed and transiently transfected murine B6 fibroblasts (13) , giving rise to a full-length human ferritin heavy-chain mRNA. The transformants express the human protein, which coassembles with the mouse heavy and light chains (16) . Treatment of these cells with the iron chelator desferrioxamine or the iron source hemin results in the regulation of the biosynthetic rate of the human protein, and the consequent decrease or increase in ferritin protein expression is not accompanied by changes in total or cytoplasmic mRNA levels (16) . We decided to investigate the molecular mechanism of this regulation by two approaches. Both focus on the 5' nontranslated region of the ferritin mRNA, which is 212 nucleotides long and could influence the expression of ferritin at the level of translation initiation or ribosome scanning. The first approach was to test the effect of a major deletion from this region on the regulation of ferritin biosynthesis. The second approach was to attempt to transfer the proposed iron-dependent translational control to a heterologous gene product, chloramphenicol acetyltransferase (CAT). We report that the deletion of a major portion of the nontranslated 5' leader sequence of the ferritin mRNA renders it unresponsive to iron. When the complete leader sequence is joined to the CAT gene, the translation of the resulting hybrid mRNA is controlled by iron.
MATERIALS AND METHODS
Construction of Ferritin-Related Recombinant Plasmids (see Fig. 1 ). The ferritin minigene (Fer-mg) is a full-length human ferritin heavy-chain cDNA under the control of its physiological promoter in the plasmid pUC18. It was generated by truncating pHF16, the cDNA clone isolated by Drysdale and colleagues (12) , at its only Sac I site and ligating the resulting 3' fragment of the cDNA to the 458-base-pair (bp) Sac I fragment of the genomic clone pUCM11 (13) , which contains the 5' promoter and leader sequences of the ferritin gene. This was followed by selection for the correct orientation and insertion into the Sac I (5')-HindIII (3') sites of pUC18. pFPBbv is a deletion construct from which nucleotides -30 to -186 of the ferritin leader sequence have been removed by truncation of the minigene and blunt-ending at a Bbv I site (-29) . The resulting fragment was inserted into the HincII (5')-HindIII (3' ) sites of the ferritin promoter construct pFP.
(for details of construction of pFP., see Results). The two recombinant plasmids pFP1-CAT and pFPL-CAT are both under the control of the ferritin promoter and express hybrid mRNAs coding for bacterial enzyme CAT. For the construction of pFPL-CAT, the 382-bp Sac I-Tthlll.I fragment from the minigene was made blunt-ended at the Tthlll.I site, isolated by gel electrophoresis, and inserted into the Sac Abbreviation: CAT, chloramphenicol acetyltransferase.
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The publication costs of this article were defrayed in part by page charge payment. This article must therefore be hereby marked "advertisement" (Fig. 2) . pFP1-CAT was generated from pFPL-CAT by digestion with BamHI and subsequent treatment with the exonuclease BAL-31. The reaction was stopped, the products were treated with DNA polymerase Klenow fragment, and the ferritin promoter fragment was released with Sac I and purified by gel electrophoresis. To determine the 3' end of this promoter fragment accurately, we subcloned it into the Sac I-Sma I sites of the replicative form of bacteriophage vector M13 mpl8 and determined its sequence by the dideoxy chain-termination method (17) . It was then recovered from the M13 replicative form and inserted into the polylinker of pUC18. Finally, the blunt-ended CAT GenBlock was inserted 3' into the HincII site and recombinant plasmids were selected for the correct orientation of the CAT structural gene with respect to the ferritin promoter fragment. 150 lCi/ml (1 Ci = 37 GBq). Immunoprecipitation of ferritin and analysis by NaDodSO4/ 16.5% polyacrylamide gel electrophoresis were done as described (16) . For determination of CAT activity, hemin (50 ttM) or desferrioxamine (50 ,LM) were added to the medium 6 hr after removal of the calcium phosphate/DNA precipitate, and the cells were subsequently incubated for 22 hr at 37°C. Lysates were prepared, after two washes with ice-cold phosphate-buffered saline, by three freeze-thaw cycles in 0.25 M Tris/HCI buffer (pH 7.4) and subsequent heating to 56°C for 10 min. For each plasmid, equal aliquots of lysate were assayed from cells treated with hemin or desfernoxamine or from untreated cells and analyzed as described (16 Cells (5.0 X 107) were transfected and treated as described above. Total RNA was prepared by solubilizing washed cells in guanidinium isothiocyanate and isolating RNA after ultracentrifugation through a 5.7 M CsCl cushion (19) . Remaining DNA was removed by extensive treatment with RNase-free DNase I (Bethesda Research Laboratories). To generate a probe, the CAT GenBlock (Pharmacia) was blunt-ended and inserted into the HincIl polylinker site of pFPO ( Fig. 1) to create pFPO-CAT. A 439-bp EcoRI fragment spanning the ferritin promoter region and the 252 most 5' nucleotides of the CAT GenBlock was excised and subcloned into pGEM-Blue (Promega Biotec). A single-stranded 450-bp "antisense" RNA probe was uniformly labeled with [a-32P]GTP by in vitro transcription from the bacteriophage T7 promoter. This transcript (105 cpm) was hybridized to 50 ,tg of total RNA and then treated with 4000 units of nuclease S1 (Boehringer Mannheim) for 30 min at 40'C. The samples were phenol-extracted, ethanol-precipitated, resuspended, denatured, and analyzed by electrophoresis in an 8 M urea/6% polyacrylamide gel.
RESULTS AND DISCUSSION
Several experimental approaches to the question of translational control of ferritin expression were taken. We first tested the prediction that the complete cDNA under the control of its physiological promoter [a construct referred to as "ferritin minigene" (Fer-mg)] should exhibit iron regulation. To ensure that a full-length mRNA would be produced, the ferritin minigene was constructed as described above and schematically depicted in Fig. 1. Fig. 3 CAT enzyme assay results of these experiments. Iron perturbation has no effect on pSV2cat [hemin/desferrioxamine CAT expression ratio (H/D) = 1.08] and only a minor effect on pFP1-CAT (H/D = 1.31). It is possible that this reflects a small transcriptional effect characteristic of the ferritin promoter. In contrast, the expression of pFPL-CAT is markedly affected by iron perturbation (H/D = 6.4). Hemin raises the relative CAT activity (expressed as percent conversion ofthe substrate) by a factor of 1.8, and desferrioxamine leads to a 3.6-fold decrease. The simultaneous addition of hemin and desferrioxamine abrogates the effect on the relative CAT activity of pFPL-CAT (data not shown). This finding demonstrates that the two agents can compete with each other and that they exhibit their effect via iron (24) . It is important to note that the nature of the CAT assay only allows us to determine the total enzyme pool. Therefore, the regulatory effect of temporary iron perturbation on the biosynthetic rate of the enzyme is likely to be underestimated and cannot be directly compared with the range of regulation of the biosynthesis of ferritin. However, nucleotide sequences contained in the coding region or the 3' untranslated region ofthe ferritin mRNA may influence the degree of regulation that is mediated via the cis-acting element of the 5' leader region.
Because the iron effect on ferritin regulation does not involve a change in ferritin mRNA levels (9, 16) and because we utilized the ferritin promoter in pFPL-CAT, one would predict that the hybrid CAT mRNA levels in cells transfected with pFPL-CAT would be unchanged after hemin or desferrioxamine treatment. Fig. 5 demonstrates the validity of this prediction and demonstrates the translational nature of the iron effect on pFPL-CAT. A nuclease S1 protection analysis was performed on total RNA samples from transiently transfected B6 cells after DNase I pretreatment. We used a saturating amount of a uniformly 32P-labeled RNA probe that was 450 nucleotides long (see Materials and Methods). Cells transfected with pFPL-CAT yield a specifically protected RNA, whereas control-transfected or B6 host cells give no specifically protected RNA. Hemin or desferrioxamine do not alter the quantity or size of the specifically protected RNAs when compared to untreated transfectants. Therefore the specific pFPL-CAT mRNA levels remain unchanged during iron perturbations, ruling out pretranslational regulation for the results shown in Fig. 4 .
It could be argued that the addition of 10 nucleotides of ferritin coding region to pFPL-CAT or the addition of 20 amino acids to the N-terminus of the CAT protein could be responsible for the iron effect observed. To exclude this possibility, we analyzed a BAL-31 deletion construct that lacks the ferritin ATG translation start site but retains almost all of the 5' leader region; the response of this construct to iron is identical to that of pFPL-CAT (data not shown). When the same BAL-31 deletion construct was linked to the gene coding for human growth hormone (hGH), the rate of Iron perturbations were performed exactly as described for Fig. 3 . Total RNA was prepared (19) and treated with DNase I. Fifty micrograms of total RNA was hybridized to a 450-nucleotide-long "antisense" RNA probe (see Materials and Methods) and then treated with nuclease S1. The samples were analyzed by polyacrylamide gel electrophoresis followed by autoradiography. Arrowhead at right indicates the position of the specific pFPL-CAT-derived band, of a size predicted by protection of the CAT sequence, the polylinker sequence, and the transcribed portion of pFP0. Size markers (lengths in nucleotides at left) were fragments generated by Hae ) secretion of hGH into the medium was regulated by iron perturbations in transiently transfected mouse fibroblasts. Since hGH secretion can more accurately reflect the biosynthetic rate of hGH, we were able to observe a much greater H/D ratio (=30) than was seen with pFPL-CAT. Actinomycin D (5 ,ug/ml) had no effect on the iron-regulated expression of hGH encoded by these constructs. Thus transcription is not required for this regulation. We therefore conclude that the 5' leader sequence of the ferritin heavy-chain mRNA is sufficient to transfer the translational regulation in response to iron to a heterologous mRNA.
Translational control of gene expression has been firmly established as an important mechanism by which prokaryotes regulate metabolic functions. More recently, elegant work on yeast, Drosophila, and cytomegalovirus has provided the first well-characterized examples from the eukaryotic kingdom. In all three cases the 5' leader sequence was shown to mediate the regulated mRNA expression. In the case of the yeast gene GCN4, the main translation initiation codon is preceded by four small open reading frames that interact with trans-acting factors (22) . Two small open reading frames are found within a region of the leader sequence of a cytomegalovirus f transcript that is necessary for the translational control of its expression (23) . In the latter case, addition of the 5' leader to an a (early)-gene construct converts the expression of the indicator protein to the 13 (or intermediate) class. The same area also contains a region of dyad symmetry that might allow a stem-and-loop structure to form. Kozak (25) has shown that experimentally introduced stem-and-loop structures can reduce the translational rate by a factor of 20. By applying the computer-modeling algorithm of Zuker and Stiegler (26), we have found that the ferritin leader sequence could allow a very high degree of intramolecular base-pairing (data not shown). Iron could influence the degree of secondary-structure formation through interaction with regulating molecules and thereby regulate the translational rate of ferritin. Biosynthesis of both the ferritin heavy and light chains is regulated by iron. Interestingly, a 31-nucleotide segment in the 5' leader sequence of the ferritin heavy chain (-179 to -148, see Fig. 2 ) has 84% homology with a similarly located region in the 5' leader sequence of the human ferritin light chain (27) . The homologous regions could represent sites that are important for interaction with a common regulatory component. Additionally, the region from nucleotides -38 to -13 ( Fig. 2) has up to 92% homology with a variable region of the human 28S rRNA (28) . Whether or not this intriguing observation is of functional importance remains to be elucidated.
This report proves that the human gene for the ferritin heavy chain is regulated by translational control. We have identified the presence of a cis-acting element in the 5' leader sequence of the mRNA coding for the heavy chain of human ferritin that is necessary for iron-dependent reversible translational regulation. We have localized this element to the region between 30 and 186 nucleotides upstream of the translation initiation site, and we have shown that the 5' leader sequence itself is sufficient to transfer iron-dependent regulation to an indicator gene. Thomas and Thomas (29) have provided indirect evidence that other ubiquitous mammalian proteins (a-and P3-tubulin, eukaryotic elongation factor la, poly(A)-binding protein, and vimentin) are under translational control during the early mitogenic response. Similar observations have been made for keratin (30) . Understanding of translational control mechanisms in mammalian cells will provide deeper insights into molecular events underlying the regulation of gene expression.
